Cargando…

Long-term Survival in a Patient with Metastatic Spinal Cord Compression from a Prostate Cancer with Ultra-high PSA: Case Report and Review of the Literature

A 77-year-old man presented to the hospital for non-ambulation of 48 hours prior to admission. He was found to have a metastatic spinal cord compression (MSCC), a PSA exceeding 27,000, and biopsy-confirmed prostate cancer. After palliative radiation (RT) to the spine and medical treatment, the pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Nhu Tram, Hotte, Sebastien, Dayes, Ian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2015
Materias:	Urology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494533/ https://www.ncbi.nlm.nih.gov/pubmed/26180666 http://dx.doi.org/10.7759/cureus.242

Ejemplares similares

Prostate MRI versus PSA screening for prostate cancer detection (the MVP Study): a randomised clinical trial
por: Nam, Robert, et al.
Publicado: (2022)

Time without PSA recurrence after radical prostatectomy as a predictor of future biochemical recurrence, metastatic disease and prostate cancer death: a prospective Scandinavian cohort study
por: Ahlberg, Mats Steinholtz, et al.
Publicado: (2022)

A phase 3 randomised study of enzalutamide plus leuprolide and enzalutamide monotherapy in high-risk non-metastatic hormone-sensitive prostate cancer with rising PSA after local therapy: EMBARK study design
por: Freedland, Stephen J, et al.
Publicado: (2021)

Observational study comparing the accuracy/variability between the ERSPC and the PCPT risk calculators for the prediction of significant prostate cancer in patients with PSA <10 ng/mL
por: Gomez Gomez, Enrique, et al.
Publicado: (2019)

Metastatic Prostate Adenocarcinoma: A Rare Presentation
por: Rodriguez, Pierre, et al.
Publicado: (2022)

Models predicting survival to guide treatment decision-making in newly diagnosed primary non-metastatic prostate cancer: a systematic review
por: Thurtle, David, et al.
Publicado: (2019)

An Unusual Case of Metastatic Prostate Cancer Presenting as a Massive Urinoma
por: Dhawan, Vikas, et al.
Publicado: (2023)

Metastatic Adenocarcinoma of the Prostate to the Brain Initially Suspected as Meningioma by Magnetic Resonance Imaging
por: Son, Young, et al.
Publicado: (2020)

Metastatic Prostate Adenocarcinoma Presenting as Acute Quadriplegia: A Case Report and Racial Disparity Analysis
por: Obaed, Nadia G, et al.
Publicado: (2022)

Prognostic Factors for Prostate Cancer Endpoints Following Biochemical Failure: A Review of the Literature
por: Nguyen, Tim, et al.
Publicado: (2015)

Prolonged Response to an IGF-1 Receptor Antibody in a Patient with Metastatic Castration Prostate Cancer with Neuroendocrine Differentiation
por: Graff, Julie N, et al.
Publicado: (2015)

A Multi-Center Retrospective Analysis Examining the Effect of Dipeptidyl Peptidase-4 Inhibitors on Progression-Free Survival in Patients With Prostate Cancer
por: Pan, Kelsey, et al.
Publicado: (2021)

Isolated metastatic dorsal spinal cord compression revealing prostatic adenocarcinoma
por: Borni, Mehdi, et al.
Publicado: (2019)

Liposarcoma of the Spermatic Cord Mimicking an Inguinal Hernia: A Case Report and Literature Review
por: Pikramenos, Konstantinos, et al.
Publicado: (2022)

Metastatic epidural spinal cord compression
por: Hamilton, Preci, et al.
Publicado: (2020)

TripleAiM1: a nationwide registry of de novo metastatic hormone-sensitive prostate cancer with prospective quality-of-life assessment
por: van Elst, Tessa, et al.
Publicado: (2023)

A Rare Case of Urinary Retention Due to Prostate Tuberculosis in Vietnam
por: Van Hau, Hoang, et al.
Publicado: (2022)

Metastatic Renal Cell Carcinoma to the Scalp: A Case Report With Review of Literature
por: Meshikhes, Huda A, et al.
Publicado: (2023)

Efficacy and safety of apalutamide in patients with metastatic castration-resistant prostate cancer (GENESIS): protocol for a multicentre, open-label, single-arm clinical trial
por: Miyake, Hideaki, et al.
Publicado: (2023)

Editorial Comment: Reasons for cessation of clean intermittent catheterization after spinal cord injury: Results from the Neurogenic Bladder Research Group spinal cord injury registry
por: Averbeck, Marcio Augusto
Publicado: (2021)

TASCI—transcutaneous tibial nerve stimulation in patients with acute spinal cord injury to prevent neurogenic detrusor overactivity: protocol for a nationwide, randomised, sham-controlled, double-blind clinical trial
por: Birkhäuser, Veronika, et al.
Publicado: (2020)

Predicting side-specific prostate cancer extracapsular extension: a simple decision rule of PSA, biopsy, and MRI parameters
por: Zapała, Piotr, et al.
Publicado: (2019)

Local and systemic morbidities of de novo metastatic prostate cancer in Singapore: insight from 685 consecutive patients from a large prospective Uro-oncology registry
por: Tan, Yu Guang, et al.
Publicado: (2020)

Protocol for a phase II, open-label exploratory study investigating the efficacy of fesoterodine for treatment of adult patients with spinal cord injury suffering from neurogenic detrusor overactivity for amelioration of autonomic dysreflexia
por: Walter, Matthias, et al.
Publicado: (2018)

Single-center experience with radium-223 in patients with castration-resistant prostate cancer and bone metastases
por: Kapoor, Anil, et al.
Publicado: (2019)

Role of cytokine therapy for renal cell carcinoma in the era of targeted agents
por: Koneru, R., et al.
Publicado: (2009)

Additional Treatments to the Local tumour for metastatic prostate cancer-Assessment of Novel Treatment Algorithms (IP2-ATLANTA): protocol for a multicentre, phase II randomised controlled trial
por: Connor, Martin John, et al.
Publicado: (2021)

AB126. Impact of HMG-CoA reductase inhibitor (statin) use on serum PSA and prostate volume in BPH patients
por: Park, Heung Jae
Publicado: (2014)

Metastatic prostate cancer men’s attitudes towards treatment of the local tumour and metastasis evaluative research (IP5-MATTER): protocol for a prospective, multicentre discrete choice experiment study
por: Connor, Martin John, et al.
Publicado: (2021)

Fatigue, quality of life and metabolic changes in men treated with first-line enzalutamide versus abiraterone plus prednisolone for metastatic castration-resistant prostate cancer (HEAT): a randomised trial protocol
por: Kvorning Ternov, Klara, et al.
Publicado: (2019)

Leiomyoma of the Prostate Treated via Holmium Laser Enucleation: A Case Report and Literature Review
por: Sano, Masayuki, et al.
Publicado: (2023)

Metastatic carcinoid tumour with spinal cord compression
por: Scott, SI, et al.
Publicado: (2012)

Imaging of metastatic epidural spinal cord compression
por: Bai, James, et al.
Publicado: (2022)

Focal Cryoablation of the Prostate: Primary Treatment in 163 Patients With Localized Prostate Cancer
por: Khan, Anwar, et al.
Publicado: (2023)

Rarest of the Rare Metastatic Tubulocystic Carcinoma of Kidney
por: Yousuf, Hira, et al.
Publicado: (2020)

Clinical and Histopathological Characteristics of Prostate Cancer Patients Taken to Palliative Transurethral Prostate Resection
por: Rojas-Manrique, Juan P, et al.
Publicado: (2019)

Disseminated Intravascular Coagulation With Excessive Fibrinolysis Following Diagnostic Prostatic Biopsy for Prostate Cancer
por: Ghallab, Muhammad, et al.
Publicado: (2022)

The “One-to-Many” Survival Analysis to Evaluate a New Treatment in Comparison With Therapeutic Alternatives Based on Reconstructed Patient Data: Enfortumab Vedotin Versus Standard of Care in Advanced or Metastatic Urothelial Carcinoma
por: Messori, Andrea, et al.
Publicado: (2022)

Contemporary Management of Chronic Prostatitis
por: Khattak, Ahmed S, et al.
Publicado: (2021)

A Case of Sex Cord-Stromal Tumor Originating in the Retroperitoneal Space
por: Șchiopu, Victor, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v7bsjqvp2tf877dr1q82qgogb9